US2012010198A1PendingUtilityA1
Methods for Treating Sleep Disorders by Cholecystokinin (CCK) Receptor B Antagonists
Est. expiryJun 6, 2025(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/00A61P 27/00A61K 45/06A61P 11/00A61K 38/2207A61K 31/5513
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for preventing or ameliorating a sleep-related breathing disorder. The method involves the use of one or a combination of cholecystokinin (CCK) receptor antagonists.
Claims
exact text as granted — not AI-modified1 . A method for preventing or ameliorating a sleep-related breathing disorder comprising administering an effective amount of at least one cholecystokinin (CCK) receptor antagonist to a subject in need of treatment thereby preventing or ameliorating the subject's sleep-related breathing disorder.
2 . The method of claim 1 , further comprising administering at least one other sleep-related breathing disorder therapeutic agent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.